IMP
Process View
response to nitrosative stress
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrosative stress stimulus. Nitrosative stress is a state often resulting from exposure to high levels of nitric oxide (NO) or the highly reactive oxidant peroxynitrite, which is produced following interaction of NO with superoxide anions.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to nitrosative stress"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MAPK1 | mitogen-activated protein kinase 1 | 1.000 | ||
| GSTM1 | glutathione S-transferase mu 1 | 1.000 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 1.000 | ||
| GSTM2 | glutathione S-transferase mu 2 (muscle) | 1.000 | ||
| GSTM4 | glutathione S-transferase mu 4 | 1.000 | Human | |
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 1.000 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 1.000 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.997 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.990 | Human | |
| PTPRR | protein tyrosine phosphatase, receptor type, R | 0.983 | ||
| RPS6KA3 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 | 0.965 | ||
| PEA15 | phosphoprotein enriched in astrocytes 15 | 0.959 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.909 | Human | |
| PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 0.831 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.814 | ||
| DUSP7 | dual specificity phosphatase 7 | 0.812 | Human | |
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.789 | ||
| GSTM3 | glutathione S-transferase mu 3 (brain) | 0.713 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.618 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.576 | ||
| ARHGAP9 | Rho GTPase activating protein 9 | 0.507 | ||
| MBP | myelin basic protein | 0.416 | ||
| ATF3 | activating transcription factor 3 | 0.412 | ||
| IER3 | immediate early response 3 | 0.378 | ||
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.374 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.337 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.308 | ||
| ATF2 | activating transcription factor 2 | 0.305 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.298 | ||
| MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 0.261 | ||
| MTPN | myotrophin | 0.255 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.237 | ||
| KLF6 | Kruppel-like factor 6 | 0.172 | ||
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.161 | ||
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.131 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.128 | ||
| DUSP4 | dual specificity phosphatase 4 | 0.127 | Human | |
| IER5 | immediate early response 5 | 0.117 | ||
| CSDA | cold shock domain protein A | 0.093 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.092 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.084 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.080 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.070 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.066 | ||
| EGR1 | early growth response 1 | 0.064 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.056 | ||
| HADH | hydroxyacyl-CoA dehydrogenase | 0.056 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.044 | ||
| RB1 | retinoblastoma 1 | 0.044 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.043 | ||
| MKNK1 | MAP kinase interacting serine/threonine kinase 1 | 0.042 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.039 | ||
| MAPK11 | mitogen-activated protein kinase 11 | 0.039 | ||
| JUN | jun proto-oncogene | 0.032 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.030 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.029 | ||
| IER2 | immediate early response 2 | 0.026 | ||
| FAM48A | family with sequence similarity 48, member A | 0.026 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.025 | ||
| DUSP16 | dual specificity phosphatase 16 | 0.024 | Human | |
| TNIP1 | TNFAIP3 interacting protein 1 | 0.024 | ||
| SLX1B | SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) | 0.022 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.020 | ||
| RPS6KA4 | ribosomal protein S6 kinase, 90kDa, polypeptide 4 | 0.019 | ||
| DUSP9 | dual specificity phosphatase 9 | 0.019 | Human | |
| CRYZ | crystallin, zeta (quinone reductase) | 0.016 | ||
| MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | 0.013 | ||
| GHR | growth hormone receptor | 0.013 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.012 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.012 | ||
| RHOB | ras homolog gene family, member B | 0.011 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.011 | ||
| AHR | aryl hydrocarbon receptor | 0.011 |